Panacea Biotec
Quick Facts: Panacea Biotec
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- New Delhi, India
- Website
- https://www.panaceabiotec.com/
- Modalities
- Oral Solid Dose, Vaccines, Sterile Injectables
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About Panacea Biotec
Panacea Biotec makes its own pharmaceutical products and also offers contract development and manufacturing services. Capabilities: Oral Solid Dose, Vaccines, Sterile Injectables. 1 manufacturing site registered with the U.S. FDA and Health Canada. Website: https://www.panaceabiotec.com/
Signal Score
Panacea Biotec FDA Inspection History
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2023-10-12 |
Panacea Biotec Pharma Limited
Malpur
Company-level
|
Drug Quality Assurance | Yes | Official Action Indicated (OAI) |
| 2022-06-08 |
Panacea Biotec Pharma Limited
Malpur
Company-level
|
Drug Quality Assurance | No | Official Action Indicated (OAI) |
Panacea Biotec FDA 483 Findings 9 observations · 2023-10-12 → 2023-10-12 ?
By subsystem
By severity
- 4 — Serious: 2
- 3 — Moderate: 2
- 2 — Minor: 5
- Repeat observations: 0
Most severe findings
-
Validation lacking for sterile drug products
"Procedures designed to prevent microbiological contamination of drug products purporting to be sterile did not include adequate validation of the aseptic process."
-
Environmental Monitoring System
"Aseptic processing areas are deficient regarding the system for monitoring environmental conditions."
-
Scientifically sound laboratory controls
"Laboratory controls do not include the establishment of scientifically sound and appropriate specifications, standards, sampling plans and test procedures designed to assure that components, drug product containers, closures, in-process materials, labeling and drug products conform to appropriate standards of identity, strength, quality and purity."
EMA Non-Compliance Statements 1
Issued: 2026-02-03